(Created page with "<html> <head> <style> #sideMenu,#top_title{ display:none; } #content{ width:100%;margin:0px;padding:0px; background:#FFF; } </style> <body> <meta charset="utf-8"> <meta htt...") |
|||
Line 18: | Line 18: | ||
<!-- 上述3个meta标签*必须*放在最前面, 任何其他内容都*必须*跟随其后! --> | <!-- 上述3个meta标签*必须*放在最前面, 任何其他内容都*必须*跟随其后! --> | ||
− | + | <link rel="stylesheet" href="https://2017.igem.org/Template:BIT/hero-slider-style/CSS?action=raw&ctype=text/css"/> | |
− | <link rel="stylesheet" href="https://2017.igem.org/Template:BIT/ | + | <!-- Hero slider style (https://codyhouse.co/gem/hero-slider/) --> |
− | < | + | |
− | + | <link rel="stylesheet" href="https://2017.igem.org/Template:BIT/templatemo-style/CSS?action=raw&ctype=text/css"/> | |
− | <link rel="stylesheet" href="https://2017.igem.org/Template:BIT/ | + | <!-- Templatemo style --> |
− | < | + | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
<!-- Animate.css --> | <!-- Animate.css --> | ||
<link rel="stylesheet" href="https://2017.igem.org/Template:BIT/animate/CSS?action=raw&ctype=text/css"/> | <link rel="stylesheet" href="https://2017.igem.org/Template:BIT/animate/CSS?action=raw&ctype=text/css"/> | ||
Line 41: | Line 35: | ||
<link rel="stylesheet" href="https://2017.igem.org/Template:BIT/style/CSS?action=raw&ctype=text/css"/> | <link rel="stylesheet" href="https://2017.igem.org/Template:BIT/style/CSS?action=raw&ctype=text/css"/> | ||
− | |||
</head> | </head> | ||
+ | <body> | ||
+ | |||
− | |||
− | |||
− | |||
<div class="fh5co-loader"></div> | <div class="fh5co-loader"></div> | ||
Line 60: | Line 52: | ||
<ul> | <ul> | ||
<li class="active"><a href="https://2017.igem.org/Team:BIT">Home</a></li> | <li class="active"><a href="https://2017.igem.org/Team:BIT">Home</a></li> | ||
− | + | <li><a href="../portfolio.html">Practice</a></li> | |
− | <li class="has-dropdown"> | + | <li class="has-dropdown"> |
− | <a href=" | + | <a href="../blog.html">Blo</a> |
<ul class="dropdown"> | <ul class="dropdown"> | ||
− | <li><a href=" | + | <li><a href="2017.igem.org/Team:BIT/design">Design</a></li> |
− | <li><a href=" | + | <li><a href="#">Demonstrate</a></li> |
− | <li><a href=" | + | <li><a href="#">Model</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
− | <li><a href=" | + | <li><a href="../about.html">Achievement</a></li> |
− | + | <li><a href="../contact.html">Notebook</a></li> | |
− | + | ||
<li class="btn-cta"><a href="#"><span>Team</span></a></li> | <li class="btn-cta"><a href="#"><span>Team</span></a></li> | ||
</ul> | </ul> | ||
Line 80: | Line 71: | ||
</div> | </div> | ||
</nav> | </nav> | ||
− | + | ||
− | + | ||
− | </ | + | <div class="row animate-box"> |
+ | <div class="col-md-8 col-md-offset-2 text-center fh5co-heading"> | ||
+ | <h2>Abstract</h2> | ||
+ | <p><font size=3>Cancer is one of the three major killers that threatened mankind since the 21st century. The reason is that it is not taken seriously at the beginning of cancer until it is detected in the middle and late stages, resulting in a very low cure rate. Therefore, early detection becomes a decisive factor to improve the cure rate of cancer. In this project, we use alpha-fetoprotein (AFP)as an example, using the factor that AFP can specifically bind to the aptamer, to achieve a signal conversion that using a small molecule (lysine) to replace AFP content in serum, just like equivalent substitutions in mathematics, to achieve the early detection of liver cancer. This system can be extended to all of the disease detection, which use protein as biomarkers.</font> </div> | ||
+ | </div> | ||
+ | <div class="col-md-8 col-md-offset-2 text-center fh5co-heading"> | ||
+ | <h2>Introduction</h2> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="row"> | ||
+ | <div class="col-md-5 animate-box"> | ||
+ | <div class="user-frame"> | ||
+ | <h3>Technical significance:</h3> | ||
+ | <p>After the lysine has been dissociated from complementary chain, it will induce the growth of E.coli ΔLysA, which can hardly grow without the addition of lysine. Thus we have transformed our own-designed circuit to the E.coli ΔLysA, which can express fluorescent protein as it grows. In this way, we can transform the concentration of lysine to the fluorescent intensity which can be detected through the machine.</span><br> | ||
+ | <img src="." alt="Free HTML5 Bootstrap Template" class="img-responsive img-rounded"> | ||
+ | <center/> | ||
+ | Figure 1 :The Structure Model of AFP<br> | ||
+ | <p> | ||
+ | |||
+ | </div> | ||
+ | </div> | ||
+ | <div class="col-md-7 animate-box"> | ||
+ | <h3>Clinical significance:</h3> | ||
+ | |||
+ | <p>But the concentration of the lysine is very low, resulting in a low fluorescent intensity. To solve this problem, we designed a strong promoter, cyclic amplifier system and a dual fluorescence system in our genetic circuit to ensure a much higher signal strength and sensitivity, which is definitely beneficial to our detection of AFP. </p> | ||
+ | </blockquote> | ||
+ | <p>The conventional method is ELISA and other antibody-based techniques to enrich low-abundance molecular markers. ELISA which is based on "antigen-antibody reaction" of the detection method is a little bit expensive. Time and temperature are having a greater impact for its detection. </p> | ||
+ | <blockquote> | ||
+ | <p>The purpose of this project is to establish a detection platform suitable for most molecular markers. The platform is low cost, simple to operate and has strong anti - interference ability. </p> | ||
+ | <center> | ||
+ | <div> | ||
+ | <div class="cd-full-width"> | ||
+ | <div class="container-fluid js-tm-page-content" data-page-no="4" data-page-type="gallery"> | ||
+ | <div class="tm-img-gallery-container tm-img-gallery-container-3"> | ||
+ | <div class="tm-img-gallery gallery-three"> | ||
+ | |||
+ | <div class="grid-item"> | ||
+ | <figure class=""> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/e/ec/BIT_Figure_About_The_Secondary_Structure_of_AP273.png" alt="Image" class="img-fluid tm-img"> | ||
+ | <center/> | ||
+ | Figure 2 :The 3D Structure of AP273<br> | ||
+ | <figcaption> | ||
+ | <a href="https://static.igem.org/mediawiki/2017/7/7a/Work-02.jpg">View more</a> | ||
+ | </figcaption> | ||
+ | </figure> | ||
+ | </div> | ||
+ | <div class="grid-item"> | ||
+ | <figure class=""> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/6/62/BIT_Figure_About_A_3-D_Interacting_Mode_Observed_from_Two_Views.png" alt="Image" class="img-fluid tm-img"> | ||
+ | <center/> | ||
+ | <br> | ||
+ | Figure 3 :The 3D Structure of AP273<br> | ||
+ | <figcaption> | ||
+ | <a href="img/tm-img-12.jpg">View more</a> | ||
+ | </figcaption> | ||
+ | </figure> | ||
+ | </div> | ||
+ | |||
+ | </div> | ||
+ | </div> <!-- .tm-img-gallery-container --> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="row animate-box"> | ||
+ | <div class="col-md-8 col-md-offset-2 text-center fh5co-heading"> | ||
+ | <p><font size=3>This project uses the AP273 with the highest binding to AFP and the complementary chain paired with the aptamer. | ||
+ | Aptamer is an oligonucleotide sequence or short polypeptide obtained by in vitro screening. Aptamer, as an alternative to the antibody, can bind to the corresponding ligand with high affinity and strong specificity. Its low price, easy to screen synthesis, the nature of stability and other advantages are widely used in the detection of molecular markers of disease. Its presence provides a new way to quickly and efficiently identify bio-makers.</font></span><br> | ||
+ | <center> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/8/8c/BIT_Figure_About_The_3D_Structure_of_AP273.png" alt="Free HTML5 Bootstrap Template" class="img-responsive img-rounded"> | ||
+ | <center/> | ||
+ | Figure 4 :The 3D Structure of AP273<br> | ||
+ | <p> | ||
+ | <div class="row animate-box"> | ||
+ | <div class="col-md-8 col-md-offset-2 text-center fh5co-heading"> | ||
+ | <h2>principle</h2> | ||
+ | <p><font size=3>First of all, we select an aptamers AP273, which could best affinity for AFP. We modified a biotin at the end of its 5’ end, which could affinity for streptavidin. Because of the presence of streptavidin-modified beads, aptamer has been locked firmly on beads. At the same time, a complementary chain was synthesized in its protein binding site. We modified an amino at the 3’ end of the complementary chain which can be combined with lysine protected by BOC anhydride to link lysine to the complementary chain. Because Van der Waals forces between AFP and aptamers is stronger than hydrogen bond, due to the action of magnet lying at the bottom of the reaction system, aptamers are separated from complementary chain, one at the bottom, the other in the supernatant. At this point, with the action of trypsin, lysine can be separated from the complementary chain, and start his adventure.</font> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
<div id="fh5co-started"> | <div id="fh5co-started"> | ||
<div class="overlay"></div> | <div class="overlay"></div> | ||
Line 88: | Line 162: | ||
<div class="row animate-box"> | <div class="row animate-box"> | ||
<div class="col-md-8 col-md-offset-2 text-center fh5co-heading"> | <div class="col-md-8 col-md-offset-2 text-center fh5co-heading"> | ||
− | + | <h2>Hire Us!</h2> | |
<p>Facilis ipsum reprehenderit nemo molestias. Aut cum mollitia reprehenderit. Eos cumque dicta adipisci architecto culpa amet.</p> | <p>Facilis ipsum reprehenderit nemo molestias. Aut cum mollitia reprehenderit. Eos cumque dicta adipisci architecto culpa amet.</p> | ||
<p><a href="#" class="btn btn-default btn-lg">Contact Us</a></p> | <p><a href="#" class="btn btn-default btn-lg">Contact Us</a></p> |
Revision as of 16:01, 31 October 2017
Abstract
Cancer is one of the three major killers that threatened mankind since the 21st century. The reason is that it is not taken seriously at the beginning of cancer until it is detected in the middle and late stages, resulting in a very low cure rate. Therefore, early detection becomes a decisive factor to improve the cure rate of cancer. In this project, we use alpha-fetoprotein (AFP)as an example, using the factor that AFP can specifically bind to the aptamer, to achieve a signal conversion that using a small molecule (lysine) to replace AFP content in serum, just like equivalent substitutions in mathematics, to achieve the early detection of liver cancer. This system can be extended to all of the disease detection, which use protein as biomarkers.
Introduction
Technical significance:
After the lysine has been dissociated from complementary chain, it will induce the growth of E.coli ΔLysA, which can hardly grow without the addition of lysine. Thus we have transformed our own-designed circuit to the E.coli ΔLysA, which can express fluorescent protein as it grows. In this way, we can transform the concentration of lysine to the fluorescent intensity which can be detected through the machine.
Clinical significance:
But the concentration of the lysine is very low, resulting in a low fluorescent intensity. To solve this problem, we designed a strong promoter, cyclic amplifier system and a dual fluorescence system in our genetic circuit to ensure a much higher signal strength and sensitivity, which is definitely beneficial to our detection of AFP.
The conventional method is ELISA and other antibody-based techniques to enrich low-abundance molecular markers. ELISA which is based on "antigen-antibody reaction" of the detection method is a little bit expensive. Time and temperature are having a greater impact for its detection.
The purpose of this project is to establish a detection platform suitable for most molecular markers. The platform is low cost, simple to operate and has strong anti - interference ability.
This project uses the AP273 with the highest binding to AFP and the complementary chain paired with the aptamer.
Aptamer is an oligonucleotide sequence or short polypeptide obtained by in vitro screening. Aptamer, as an alternative to the antibody, can bind to the corresponding ligand with high affinity and strong specificity. Its low price, easy to screen synthesis, the nature of stability and other advantages are widely used in the detection of molecular markers of disease. Its presence provides a new way to quickly and efficiently identify bio-makers.
![Free HTML5 Bootstrap Template](https://static.igem.org/mediawiki/2017/8/8c/BIT_Figure_About_The_3D_Structure_of_AP273.png)
principle
First of all, we select an aptamers AP273, which could best affinity for AFP. We modified a biotin at the end of its 5’ end, which could affinity for streptavidin. Because of the presence of streptavidin-modified beads, aptamer has been locked firmly on beads. At the same time, a complementary chain was synthesized in its protein binding site. We modified an amino at the 3’ end of the complementary chain which can be combined with lysine protected by BOC anhydride to link lysine to the complementary chain. Because Van der Waals forces between AFP and aptamers is stronger than hydrogen bond, due to the action of magnet lying at the bottom of the reaction system, aptamers are separated from complementary chain, one at the bottom, the other in the supernatant. At this point, with the action of trypsin, lysine can be separated from the complementary chain, and start his adventure.
Hire Us!
Facilis ipsum reprehenderit nemo molestias. Aut cum mollitia reprehenderit. Eos cumque dicta adipisci architecto culpa amet.